RTL10 and chronic myelogenous leukemia, BCR-ABL1 positive: Previous studies have shown that imatinib activated pro-apoptotic BH3-only protein BIM, which is regarded as a major role in imatinib induced apoptosis of the BCR-ABL1 positive CML cells [34, 35].